Vitreous modulation of gene expression in low-passage human retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 4, 2007, Pages 1853-1863

  Ganti, Ramapriya ^a,b   Hunt, Richard C ^a   Parapuram, Sunil K ^a,c   Hunt, D Margaret ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; EYE PROTEIN;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION; VITREORETINOPATHY; VITREOUS BODY; CELL CULTURE; CYTOLOGY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; EYE PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; VITREOUS BODY;

EID: 34248377348     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0198     Document Type: Article

References (64)

1. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845-881.
2. Campochiaro PA. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol. 1997;115:237-241.
3. Pastor JC. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 1998;43:3-18.
4. Machemer R. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Invest Ophthalmol Vis Sci. 1988;29:1771-1783.
5. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999;18:167-190.
6. Mandelcorn MS, Machemer R, Fineberg E, Hersch SB. Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants. Am J Ophthalmol. 1975;80:227-237.
7. Vidaurri-Leal J, Hohman R, Glaser BM. Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells: a new approach to the study of proliferative vitreoretinopathy. Arch Ophthalmol. 1984;102:1220-1223.
8. Kirchhof B, Sorgente N. Pathogenesis of proliferative vitreoretinopathy: modulation of retinal pigment epithelial cell functions by vitreous and macrophages. Dev Ophthalmol. 1989;16:1-53.
9. Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 2002;21:127-144.
10. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol. 2000;184:301-310.
11. Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res. 1998;17:77-98.
12. Hunt DM, Chen W, Hunt RC. Vitreous treatment of retinal pigment epithelial cells results in decreased expression of FGF-2. Invest Ophthalmol Vis Sci. 1998;39:2111-2120.
13. Kociok N, Hueber A, Esser P, et al. Vitreous treatment of cultured human RPE cells results in differential expression of 10 new genes. Invest Ophthalmol Vis Sci. 2002;43:2474-2480.
14. Fan W, Zheng JJ, Peiper SC, McLaughlin BJ. Changes in gene expression of ARPE-19 cells in response to vitreous treatment. Ophthalmic Res. 2002;34:357-365.
15. Parapuram SK, Ganti R, Hunt RC, Hunt DM. Vitreous induces components of the prostaglandin E2 pathway in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:1767-1774.
16. Davis AA, Bernstein PS, Bok D, Turner J, Nachtigal M, Hunt RC. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol Vis Sci. 1995;36:955-964.
17. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116-5121.
18. Diehn M, Sherlock G, Binkley G, et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res. 2003;31:219-223.
19. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:R70.
20. Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005;33:W741-W748.
21. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004;32:D277-D280.
22. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25-29.
23. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:R70.
24. Khatri P, Bhavsar P, Bawa G, Draghici S. Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments. Nucleic Acids Res. 2004;32:W449-W456.
25. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:2002-2007.
26. Pfaffl MW. Quantification strategies in real-time PCR. In: Bustin SA, ed. A-Z of Quantitative PCR. La Jolla, CA: International University Line; 2004:Chap. 3:1-23.
27. Meitinger D, Hunt DM, Shin D, Fox JC, Hunt RC. Vitreous-induced modulation of integrins in retinal pigment epithelial cells: effects of fibroblast growth factor-2. Exp Eye Res. 2001;73:681-692.
28. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat. 1995;154:8-20.
29. De Craene B, Van Roy F, Berx G. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal. 2005;17:535-547.
30. Birchmeier C, Birchmeier W, Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat. 1996;156:217-226.
31. Hinton DR, He S, Jin ML, Barron E, Ryan SJ. Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye. 2002;16:422-428.
32. Hiscott P, Hagan S, Heathcote L, et al. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye. 2002;16:393-403.
33. Tanaka Y, Utsumi J, Matsui M, et al. Purification, molecular cloning, and expression of a novel growth-promoting factor for retinal pigment epithelial cells, REF-1/TFPI-2. Invest Ophthalmol Vis Sci. 2004;45:245-252.
34. Chen C, Young BA, Coleman CS, Pegg AE, Sheppard D. Spermidine/spermine N1-acetyltransferase specifically binds to the integrin alpha9 subunit cytoplasmic domain and enhances cell migration. J Cell Biol. 2004;167:161-170.
35. Hartung RA, Parapuram SK, Ganti R, Hunt DM, Chalam KV, Hunt RC. Vitreous induces an antioxidant response mediated in part by TGF-beta and reactive oxygen species generation in human retinal pigment epithelial cells. Mol Vis. 2007;13:66-78.
36. Bost LM, Aotaki-Keen AE, Hjelmeland LM. Coexpression of FGF-5 and bFGF by the retinal pigment epithelium in vitro. Exp Eye Res. 1992;55:727-734.
37. Hanneken A, Baird A. Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid. Invest Ophthalmol Vis Sci. 1995;36:1192-1196.
38. Saika S. TGFbeta pathobiology in the eye. Lab Invest. 2006;86:106-115.
39. Chowers I, Liu D, Farkas RH, et al. Gene expression variation in the adult human retina. Hum Mol Genet. 2003;12:2881-2893.
40. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403-439.
41. Birchmeier C, Birchmeier W. Molecular aspects of mesenchymal-epithelial interactions. Ann Rev Cell Biol. 1993;9:511-540.
42. Savagner P, Kusewitt DF, Carver EA, et al. Developmental transcription factor Slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol. 2005;202:858-866.
43. Come C, Arnoux V, Bibeau F, Savagner P. Roles of the transcription factors Snail and Slug during mammary morphogenesis and breast carcinoma progression. J Mammary Gland Biol Neoplasia. 2004;9:183-193.
44. Frisch SM, Ruoslahti E. Integrins and anoikls. Curr Opin Cell Biol. 1997;9:701-706.
45. Martinez-Morales JR, Rodrigo I, Bovolenta P. Eye development: a view from the retina pigmented epithelium. Bioessays. 2004;26:766-777.
46. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005;24:5764-5774.
47. Armstrong EJ, Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res. 2004;95:459-470.
48. Saika S, Kono-Saika S, Tanaka T, et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest. 2004;84:1245-1258.
49. Connor TB Jr, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666.
50. Gaudric A, Glacet-Bernard A, Clement G, Falquerho L, Barritault D, Coscas G. Transforming growth factor beta in the vitreous of patients with epiretinal proliferation. Ophtalmologie. 1990;4:51-52.
51. Esser P, Heimann K, Bartz-Schmidt KU, et al. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis. Exp Eye Res. 1997;65:365-378.
52. Kon CH, Occleston NL, Aylward GW, Khaw PT. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci. 1999;40:705-712.
53. El Ghrably I, Powe DG, Orr G, et al. Apoptosis in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2004;45:1473-1479.
54. Pfeffer BA, Flanders KC, Guerin CJ, Danielpour D, Anderson D. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of monkey eye. Exp Eye Res. 1994;59:323-333.
55. Yue J, Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther. 2001;91:1-34.
56. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18:816-827.
57. Grotendorst GR, Rahmanie H, Duncan MR. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J. 2004;18:469-479.
58. Harris SE, Guo D, Harris MA, Krishnaswamy A, Lichtler A. Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: role of Dlx2 and Dlx5 transcription factors. Front Biosci. 2003;8:s1249-s1265.
59. Ji X, Chen D, Xu C, Harris SE, Mundy GR, Yoneda T. Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab. 2000;18:132-139.
60. Ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ. Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol. 2003;211:105-113.
61. Lee KS, Kim HJ, Li QL, et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 2000;20:8783-8792.
62. Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14:1239-1249.
63. Miyazono K, Miyazawa K. Id: a target of BMP signaling. Sci STKE. 2002;E40:1-3.
64. Whitman M, Raftery L. TGFbeta signaling at the summit. Development. 2005;132:4205-4210.